Annual Cash & Cash Equivalents
$20.10B$4.42B-18.02%
Summary
- Current Value
- As of today, JNJ annual cash & cash equivalents is $20.10B, down -18.02% on
- Historical Performance
- JNJ annual cash & cash equivalents is down -9.78% over the past 3 years, down -20.18% over the past 5 years
- All-Time High Comparison
- JNJ annual cash & cash equivalents is currently -52.03% below its historical high of $41.91B set on
- 3-Year Low Comparison
- JNJ annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- JNJ annual cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $20.10B | -18.0% | -9.8% | -20.2% | -27.3% | |
| Quarterly Cash & Cash Equivalents | $20.10B | -18.0% | -9.8% | -20.2% | -27.3% | |
| Price | $243.45 | +54.8% | +49.6% | +46.1% | +301.1% | |
| Annual Current Assets | $55.62B | -0.5% | +0.6% | +8.6% | +17.6% | |
| Annual Total Liabilities | $117.67B | +8.3% | +6.4% | +5.4% | +154.0% | |
| Annual Working Capital | $1.50B | -73.1% | +394.9% | -82.9% | -93.8% | |
| Annual Net Income | $26.80B | +90.6% | +63.7% | +82.2% | +101.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $24.52B | -18.0% | |
| 5Y | $31.61B | -36.4% | |
| All | $41.91B | -52.0% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $20.10B | at low | |
| 5Y | $20.10B | at low | |
| All | $442.50M | +4442.8% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of JNJ?
As of today, JNJ annual cash & cash equivalents is $20.10B
What is 1-year change in JNJ annual cash & cash equivalents?
JNJ annual cash & cash equivalents is down -18.02% year-over-year
What is 3-year change in JNJ annual cash & cash equivalents?
JNJ annual cash & cash equivalents is down -9.78% over the past 3 years
How far is JNJ annual cash & cash equivalents from its all-time high?
JNJ annual cash & cash equivalents is currently -52.03% below its historical high of $41.91B set on December 1, 2016
How does JNJ annual cash & cash equivalents rank versus sector peers?
JNJ annual cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
When is JNJ next annual earnings release?
As of today, the next annual earnings release for JNJ has not been scheduled
Quarterly Cash & Cash Equivalents
$20.10B$1.54B+8.30%
Summary
- Current Value
- As of today, JNJ quarterly cash & cash equivalents is $20.10B, up +8.30% on
- Historical Performance
- JNJ quarterly cash & cash equivalents is down -18.02% year-over-year, down -9.78% over the past 3 years
- All-Time High Comparison
- JNJ quarterly cash & cash equivalents is currently -52.79% below its historical high of $42.58B set on
- 3-Year Low Comparison
- JNJ quarterly cash & cash equivalents is +8.30% above its 3-year low of $18.56B reached on
- Sector Comparison
- JNJ quarterly cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $20.10B | +8.3% | -18.0% | -9.8% | -20.2% | |
| Annual Cash & Cash Equivalents | $20.10B | – | -18.0% | -9.8% | -20.2% | |
| Price | $243.45 | +24.7% | +54.8% | +49.6% | +46.1% | |
| Quarterly Current Assets | $55.62B | +1.9% | -0.5% | +0.6% | +8.6% | |
| Quarterly Total Liabilities | $117.67B | +3.6% | +8.3% | +6.4% | +5.4% | |
| Quarterly Working Capital | $1.50B | -60.0% | -73.1% | +394.9% | -82.9% | |
| Quarterly Net Income | $5.12B | -0.7% | +49.1% | +58.5% | +194.4% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $38.78B | -48.2% | |
| 3Y | $38.78B | -48.2% | |
| 5Y | $38.78B | -48.2% | |
| All | $42.58B | -52.8% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.56B | +8.3% | |
| 3Y | $18.56B | +8.3% | |
| 5Y | $18.56B | +8.3% | |
| All | $334.00M | +5918.6% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of JNJ?
As of today, JNJ quarterly cash & cash equivalents is $20.10B
What is JNJ quarterly cash & cash equivalents most recent change?
JNJ quarterly cash & cash equivalents was up +8.30% on December 31, 2025
What is 1-year change in JNJ quarterly cash & cash equivalents?
JNJ quarterly cash & cash equivalents is down -18.02% year-over-year
How far is JNJ quarterly cash & cash equivalents from its all-time high?
JNJ quarterly cash & cash equivalents is currently -52.79% below its historical high of $42.58B set on June 1, 2016
How does JNJ quarterly cash & cash equivalents rank versus sector peers?
JNJ quarterly cash & cash equivalents is higher than 99.91% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- JNJ Official Website www.jnj.com
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj